Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yanxia Ji
Observed names:
Yanxia JI,
Yan‐Xia Ji
Institution:
Ningxia Medical University General Hospital
Observed institutions:
Shanghai Chest Hospital,
Ningxia Medical University General Hospital,
First Affiliated Hospital of Bengbu Medical College,
Jilin Agricultural University
OpenAlex ID:
A5064470279
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial
2025
·
Xiaotian Zhang
, Jufeng Wang
, et al.
·
JAMA
·
97
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study
2024
·
Jin Li
, Zhendong Chen
, et al.
·
Nature Medicine
·
61
PDF
Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer
2019
·
Yunpeng Yang
, Bin Wu
, et al.
·
Translational Lung Cancer Research
·
37
PDF
miR‐874‐3p inhibits cell migration through targeting RGS4 in osteosarcoma
2020
·
Wei‐Gang Liu
, Lei Zhuo
, et al.
·
The Journal of Gene Medicine
·
30
Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals
2014
·
Lisha Wei
, Yanxia Ji
, et al.
·
Drug Development and Industrial Pharmacy
·
30
Ginsenosides Extracted from Nanoscale Chinese White Ginseng Enhances Anticancer Effect
2012
·
Yanxia Ji
, Ziyu Rao
, et al.
·
Journal of Nanoscience and Nanotechnology
·
18
Atractylenolide III Enhances the Anti-Neoplastic Efficacy of Docetaxel in Gastric Cancer Cell by Inhibiting Fibroblast Growth Factor Receptors 1, -2, and -4 Expression
2019
·
Yanxia Ji
, Zhenqiao Kang
, et al.
·
Journal of Environmental Pathology Toxicology and Oncology
·
12
A 12-week WeChat education, relaxing, and care program relieves anxiety, depression, insomnia, and posttraumatic stress disorder in parents of childhood lymphoma patients
2024
·
Zhongyu Wang
, Zhongya Wang
, et al.
·
Hematology
·
8
PDF
CS1001-304: A phase III study of fluorouracil and cisplatin (FP) with CS1001, an anti-PD-L1 antibody, or placebo in unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC).
2021
·
Jin Li
, Yuxian Bai
, et al.
·
Journal of Clinical Oncology
·
2
FAM49B mediates tumor progression and poor prognosis of gastric cancer through activating PI3K/AKT pathway
2025
·
Huimin Yang
, Yanxia Ji
, et al.
·
Journal of Molecular Histology
·
1
Changes of C-reactive protein and insulin resistance in perioperative period of on-pump and off-pump coronary artery bypass grafting
2024
·
Yanyan Song
, Yanxia Ji
·
Asian Journal of Surgery
Levosimendan for patients with heart failure after aortic valve replacement
2024
·
Chao Han
, Yanxia Ji
, et al.
·
Asian Journal of Surgery
Evaluation of sequential application of epidermal growth factor receptor-tyrosine kinase inhibitor(EGFR-TKI) after chemotherapy in advanced non-small cell lung cancerpatients with EGFR-TKI acquired resistance
2018
·
Yanxia Ji
, Zhenqiao Kang
, et al.
·
Chin J Postgrad Med
Concurrent Chemo-radiotherapy Plus Adjuvant Chemotherapy for Locally Advanced Non Small Cell Lung Cancer
2007
·
Yanxia Ji
·
The Practical Journal of Cancer
The Expression of Vascular Endothelial Growth Factor in Breast Cancer Cell Lines
2006
·
Yanxia Ji
·
Carcinogenesis,Teratogenesis and Mutagenesis
Show more works
View as search
Works count:
15
Citation count:
296
H-index:
8
I10-index:
7
Year
Topic
Type